Back to discover
Disease
Thrombophilia
Late-stage therapeutic developmentEmerging research
1
Publications
6
Clinical trials
2020
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Research2020-01-01Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
No activity recorded in this window. Try a wider timeframe.
Clinical trials
The current development programme across all trial phases.
Clinical programme
6
0
3
3
Late-stage studies
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes2
- Betacoronavirus1
- Pandemics1
Leading journals1
- Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis1
Leading researchers2
- Makris M1
- Miesbach W1
Affiliations (unnormalised)3
- Department of Haemostaseology and Hemophilia Center1
- Sheffield Haemophilia and Thrombosis Centre1
- University of Sheffield1
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.